Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (401-410 of 683) with videos related to

Pageof 69
Sort By:
JAMA Network Open|February 2, 2023
Predictive Value of Early Autism Detection Models Based on Electronic Health Record Data Collected Before Age 1 YearMatthew M Engelhard, Ricardo Henao, Samuel I Berchuck, et al.
Gynecologic Oncology|April 23, 2013
Transcript expression in endometrial cancers from Black and White patientsG Larry Maxwell, Jay Allard, Chandramouli V R Gadisetti, et al.
Cancer Causes & Control : CCC|January 31, 2026
Self-collected biospecimen consent and return rates in a population-based study among women with ovarian cancer: insights from the ORCHiD studyApril Deveaux, Drew Neish, Ashwini Joshi, et al.
Journal of Clinical Pathology|November 24, 1999
Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutationsR P Zweemer, P A Shaw, R M Verheijen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 9, 2022
Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD StudyMary Katherine Montes de Oca, Lauren E Wilson, Rebecca A Previs, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 15, 2021
Endometrial Adenocarcinomas With No Specific Molecular Profile: Morphologic Features and Molecular Alterations of "Copy-number Low" TumorsVivienne T Meljen, Rhonda Mittenzwei, Janice Wong, et al.
The Prostate|September 10, 2024
A panel-based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration-resistant prostate cancerDaniel Boiarsky, Alok K Tewari, Doga C Gulhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expressionJohn Ian Risinger, Gadisetti V R Chandramouli, G Larry Maxwell, et al.
Contemporary Clinical Trials Communications|April 20, 2023
mHealth Coping Skills Training for Symptom Management (mCOPE) for colorectal cancer patients in early to mid-adulthood: Study protocol for a randomized controlled trialKelly A Hyland, Grace H Amaden, Allison K Diachina, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 29, 2009
Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neuAmy A Hakim, Catherine P Barry, H John Barnes, et al.
Pageof 69

Showing results (401-410 of 683) with videos related to

Sort By:
Pageof 69
JAMA Network Open|February 2, 2023
Predictive Value of Early Autism Detection Models Based on Electronic Health Record Data Collected Before Age 1 YearMatthew M Engelhard, Ricardo Henao, Samuel I Berchuck, et al.
Gynecologic Oncology|April 23, 2013
Transcript expression in endometrial cancers from Black and White patientsG Larry Maxwell, Jay Allard, Chandramouli V R Gadisetti, et al.
Cancer Causes & Control : CCC|January 31, 2026
Self-collected biospecimen consent and return rates in a population-based study among women with ovarian cancer: insights from the ORCHiD studyApril Deveaux, Drew Neish, Ashwini Joshi, et al.
Journal of Clinical Pathology|November 24, 1999
Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutationsR P Zweemer, P A Shaw, R M Verheijen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 9, 2022
Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD StudyMary Katherine Montes de Oca, Lauren E Wilson, Rebecca A Previs, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 15, 2021
Endometrial Adenocarcinomas With No Specific Molecular Profile: Morphologic Features and Molecular Alterations of "Copy-number Low" TumorsVivienne T Meljen, Rhonda Mittenzwei, Janice Wong, et al.
The Prostate|September 10, 2024
A panel-based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration-resistant prostate cancerDaniel Boiarsky, Alok K Tewari, Doga C Gulhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expressionJohn Ian Risinger, Gadisetti V R Chandramouli, G Larry Maxwell, et al.
Contemporary Clinical Trials Communications|April 20, 2023
mHealth Coping Skills Training for Symptom Management (mCOPE) for colorectal cancer patients in early to mid-adulthood: Study protocol for a randomized controlled trialKelly A Hyland, Grace H Amaden, Allison K Diachina, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 29, 2009
Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neuAmy A Hakim, Catherine P Barry, H John Barnes, et al.
Pageof 69